EMA updates COVID-19 vaccine risk management plans to reflect variant safety
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsComplianceEuropeProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/Policy